Cell-penetrating peptides: classes, origin, and current landscape

F Milletti - Drug discovery today, 2012 - Elsevier
With more than ten new FDA approvals since 2001, peptides are emerging as an important
therapeutic alternative to small molecules. However, unlike small molecules, peptides on the …
被引用次数：1012 相关文章

Cell-penetrating peptides: classes, origin, and current landscape

F Milletti - Drug discovery today, 2012 - pubmed.ncbi.nlm.nih.gov
With more than ten new FDA approvals since 2001, peptides are emerging as an important
therapeutic alternative to small molecules. However, unlike small molecules, peptides on the …

Cell-penetrating peptides: classes, origin, and current landscape.

F Milletti - Drug Discovery Today, 2012 - europepmc.org
With more than ten new FDA approvals since 2001, peptides are emerging as an important
therapeutic alternative to small molecules. However, unlike small molecules, peptides on the …

Cell-penetrating peptides: classes, origin, and current landscape

F Milletti - Drug Discovery Today, 2012 - infona.pl
With more than ten new FDA approvals since 2001, peptides are emerging as an important
therapeutic alternative to small molecules. However, unlike small molecules, peptides on the …

[引用][C] Cell-penetrating peptides: classes, origin, and current landscape

F MILLETTI - Drug discovery today, 2012 - pascal-francis.inist.fr
Cell-penetrating peptides: classes, origin, and current landscape CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

[引用][C] Cell-penetrating peptides: classes, origin, and current landscape

F Milletti - Drug Discovery Today, 2012 - cir.nii.ac.jp
Cell-penetrating peptides: classes, origin, and current landscape | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

[引用][C] Cell-penetrating peptides: classes, origin, and current landscape

F MILLETTI - Drug discovery today, 2012 - Elsevier